,7 The most widely used breast cancer categorization approach is based on molecular subtyping of biomarkers such as estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor 2 (HER2) receptors. This evidence concerns the gene ERBB2 and breast carcinoma.